| RYTM Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the RYTM shares outstanding history going back to 10/5/2017:
Also see: RYTM Market Cap History RYTM YTD Return |
RYTM Shares Outstanding History — Rhythm Pharmaceuticals Share Count Over Time
As of 5/1/2026 Rhythm Pharmaceuticals has 68.53 million RYTM shares outstanding. Investors often track the RYTM shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows RYTM share count trends over time, with 34 historical shares outstanding datapoints presented, dating back to 10/5/2017.
| RYTM Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RYTM Historical Shares Outstanding: +12.12% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RYTM Stock Price Chart |
| About Rhythm Pharmaceuticals Inc |
| Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE. IMCIVREE is a precision medicine approved by the FDA for chronic weight management in adults and children aged six and older with monogenic or syndromic obesity due to POMC, PCSK1, or LEPR deficiencies, or Bardet-Biedl syndrome (BBS). The company is also evaluating setmelanotide in Phase II and III trials for treating obesity linked to various MC4R pathway gene variants. We show 34 historical shares outstanding datapoints in our coverage of RYTM's shares outstanding history. Understanding the changing numbers of RYTM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RYTM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RYTM by allowing them to research RYTM shares outstanding history as well as any other stock in our coverage universe. |
| RYTM Current Stock Quote |
Quotes delayed 20 minutes  Free RYTM Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| RYTM Share Performance |
| Shares Outstanding Peers |
| Rhythm Pharmaceuticals (RYTM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RYZB Shares Outstanding History RZLT Shares Outstanding History SABS Shares Outstanding History SAGE Shares Outstanding History SANA Shares Outstanding History SAVA Shares Outstanding History SBFM Shares Outstanding History SBPH Shares Outstanding History SBTX Shares Outstanding History SCPH Shares Outstanding History More Healthcare companies » |
RYTM Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
